Cronos Group is an innovative global cannabinoid company
With international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™.
Our management team comprises experts in their fields, with a goal to establish the most valuable international cannabis company. They are passionate, daring people, driven by quality and integrity, who are determined to write history, not read about it.
Large_Logo_1_Cronos_Group.pngCronos Fermentation
Winnipeg, Manitoba
Cronos Fermentation is a GMP-standard fermentation and manufacturing facility in Winnipeg, Manitoba. The state-of-the-art facility includes fully equipped laboratories covering microbiology, organic and analytical chemistry, quality control and method development as well as two large-scale microbial fermentation production areas, three downstream processing plants, and bulk product and packaging capabilities. The facility is expected to provide the fermentation and manufacturing capabilities we need in order to capitalize on the progress underway with Ginkgo, by enabling us to produce the target cannabinoids contemplated under the Ginkgo Collaboration Agreement at commercial scale with high quality and high purity.
3_Cronos_Fermentation_opt.jpg1technionogbcLarge_Logo_3_OGBC.pngOkanagan Valley, British Columbia
Original BC is a license holder under the Canadian Cannabis Act and is located in British Columbia’s Okanagan Valley. Known for producing some of Canada’s best cannabis, this facility leverages the reputation of the Okanagan Valley. OGBC is focused on small-batch and craft cannabis production, perfected by our team of experts.
Main_Image_3_OGBC.jpg2cfpnLarge_Logo_2_Peace_Naturals.pngStayner, Ontario
Cronos Group’s center of excellence, Peace Naturals Campus, is a license holder under the Canadian Cannabis Act and a hub for the company’s production and research and development. The campus’ state-of-the-art indoor production facilities and manufacturing facilities serve as a home for research and development in plant genetics, grow methodologies, extraction and product formulation. Peace Naturals develops industry-leading best practices, which are utilized throughout Cronos Group’s global network of production facilities. Peace Naturals production processes are Good Manufacturing Practices (GMP) certified.2_Peace_Naturals.jpg3ogbcredwoodhttps://www.peacenaturals.com/Large_Logo_16_Redwood.pngLos Angeles, California
Redwood is a hemp-derived CBD brand and products platform headquartered in Los Angeles, California. Redwood oversees Cronos Group’s operations, marketing and brand strategy for the U.S. hemp-derived CBD market. Redwood currently supports two hemp-derived CBD brands, Lord Jones™ and PEACE+™.
16Redwood.jpg4pncronos_growCoLarge_Logo_6_Cronos_GrowCo.pngKingsville, Canada
Cronos Group established a joint venture with a group of investors led by Bert Mucci, owner and operator of Mucci Farms, one of the most sophisticated greenhouse growers in North America. The Kingsville region is home to the largest concentration of greenhouses in North America and is commonly referred to as the “Sun Parlor,” since the area boasts one of the warmest climates in Canada. Cronos GrowCo is in the process of constructing a custom-built greenhouse designed to meet GAP and GMP requirements.
Main_Image_6_Cronos_GrowCo.jpg5redwoodcronos_israelLarge_Logo_4_Cronos_Israel.pngGan Shmuel, Israel
Cronos Group established a joint venture with Kibbutz Gan Shmuel, a commercial kibbutz and food company. Gan Shmuel exports to 35 countries across Europe and Asia, through Gan Shmuel Foods Ltd., and has over 1,000 agriculturally skilled kibbutz members who live on-site. Commencement of operations in Israel is subject to receiving the appropriate final cannabis cultivation and production licenses from the Israeli Ministry of Health and the cultivation and manufacturing facilities are expected to become operational in phases during 2020.
6_Cronos_Israel.jpg6cronos_growComed_menLarge_Logo_8_MedMen.pngCanada
Cronos Group has established a joint venture with MedMen, one of the most recognized cannabis retail brands, to create MedMen Canada. This partnership holds the exclusive license to the MedMen™ brand in Canada.
Main_Image_8_MedMen.jpg7cronos_israelnatuera_newnatuera_new.pngCundinamarca, Colombia
Cronos Group established a joint venture with Agroidea (AGI) to create NatuEra, the cannabis industry’s first Contract Manufacturing Organization (CMO) in LATAM. As a CMO, NatuEra intends to allow the growing number of cannabis brands worldwide to outsource their development, cultivation, and/or manufacturing activities. NatuEra is expected to be the hub and platform through which Cronos Group will access the Latin American market. NatuEra holds licenses to cultivate non-psychoactive cannabis plants and manufacture derivative products, including for export. Construction of the GMP-standard facility has commenced, and construction is anticipated to be completed in 2020, subject to obtaining the relevant permits and other customary approvals.
natuera_bg.jpg8med_mencdlhttps://natuera.com/Large_Logo_1_Cronos_Group.pngCronos Research Labs
Bet Shemesh, Israel
Cronos Research Labs is Cronos Group’s Israel-based global research and development center for innovation. The state-of-the-art facility is equipped with advanced technology and analytical testing infrastructure and is home to an experienced team of scientific talent. The Cronos Research Labs team is comprised of scientific researchers, mechanical, electrical and software engineers, and analytical and formulation scientists. Cronos Group engages in both understanding the fundamental science behind the interactions of cannabinoids with each other and how those interactions can be leveraged to best deliver on the consumer’s needs.
5_Cronos_Device_Labs_opt.jpg9natuera_newginkgo_bioworksLarge_Logo_13_GinkgoBioworks.png
Cronos Group entered into a landmark partnership to produce cultured cannabinoids at scale with Ginkgo Bioworks. Using biosynthesis as the means of production, Cronos Group and Ginkgo Bioworks will reduce the cost of pure cannabinoid production, create commercial scale and the ability to access rare cannabinoids, which are key to product differentiation and innovation. Cronos Group will have the exclusive right to use and commercialize the key patented intellectual property related to the production of the target cannabinoids perpetually and globally.
Main_Image_13_GinkgoBioworks.jpg10cdltechnionhttps://www.ginkgobioworks.com/Large_Logo_12_Technion.pngHaifa, Israel
Together with The Technion Research and Development Foundation, Cronos Group will explore the use of cannabinoids in regulating skin health and skin disorders. The research will utilize Technion’s cannabis strain database of over 80 cultivars and Cronos Group’s strain-specific cannabis oils to isolate and investigate the effects of individual and combinations of cannabinoids, for treatment of acne, psoriasis, and skin repair.
Main_Image_12_Technion.jpg11ginkgo_bioworkscfhttps://www.technion.ac.il/en/home-2/
